Cognition Network Technology: Difference between revisions

Revision as of 23:10, 20 June 2024

Latest revision as of 11:17, 21 June 2024

Line 1:

{{Multiple issues|

{{more citations needed|date=January 2015}}

{{Cleanup bare URLs|date=August 2022}}

}}

'''Cognition Network Technology''' ('''CNT'''), also known as '''Definiens Cognition Network Technology''',<ref>{{Cite web|url=http://www.ecognition.com/sites/default/files/technology.pdf|title=Image analysis with Definiens Cognition Network Technology}}</ref> is an [[object-based image analysis]] method developed by Nobel laureate [[Gerd Binnig]] together with a team of researchers at Definiens AG in Munich, Germany. It serves for extracting information from images using a hierarchy of image objects (groups of pixels), as opposed to traditional pixel processing methods.

Line 9 ⟶ 6:

==History==

In 1994 Professor Gerd Binnig founded ''Definiens''. CNT was first available with the launch of the ''eCognition'' software in May 2000. In June 2010, [[Trimble Navigation Ltd]] (NASDAQ: TRMB) acquired Definiens business asset in [[earth sciences]] markets, including eCognition software,<ref>{{Cite web | publisher=Trimble / Definiens Joint Press Release: "| title=Trimble Acquires Definiens’ Earth Sciences Business to Expand its GeoSpatial Portfolio". June| date=2010-06-11, 2010.| url=http://www.ecognition.com/sites/default/files/Trimble%20eCognition.pdf}}</ref> and also licensed Definiens' patented CNT.<ref>{{cite web | url=http://www.trimble.com/Corporate/About_History.aspx | title=About Trimble: Company History 1978 &#124; Present | access-date=2024-06-20 | archive-date=2017-04-28 | archive-url=https://web.archive.org/web/20170428055555/http://www.trimble.com/corporate/about_history.aspx | url-status=live }}</ref> In 2014, Definiens was acquired by [[MedImmune]], the global biologics research and development arm of AstraZeneca, for an initial consideration of $150 million.<ref>{{Cite web|url=https://www.astrazeneca.com/media-centre/press-releases/2014/medimmune-definiens-aquisition-tissue-phenomics-26112014.html|title=MedImmune completes acquisition of Definiens - AstraZeneca|date=November 26, 2014|website=www.astrazeneca.com|access-date=June 20, 2024|archive-date=June 20, 2024|archive-url=https://web.archive.org/web/20240620230851/https://www.astrazeneca.com/media-centre/press-releases/2014/medimmune-definiens-aquisition-tissue-phenomics-26112014.html#modal-historic-confirmation|url-status=live}}</ref>

==Software==